Andrew Peter Thomas — 48 Patents at Astrazeneca Ab

Andrew Peter Thomas has been granted 48 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1993 and the most recent in October 2019. Andrew Peter Thomas ranks #57,596 of 4,157,543 US inventors in our database (top 1.4%). Patent records list Andrew Peter Thomas in Grafton, GB.

Issued Patents All Time

Showing 1–25 of 48 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10457664	Quinazoline derivatives as VEGF inhibitors	Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin	2019-10-29
10301267	Compounds	David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou	2019-05-28	$29,638,000
9688640	Methods of treating cancer with a pyrazole derivative	David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou	2017-06-27	$63,810,000
9040548	Quinazoline derivatives as VEGF inhibitors	Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin	2015-05-26	$12,117,000
8697696	Triazole compounds II	Stephen Deems Gabriel	2014-04-15
8642608	Quinazoline derivatives as VEGF inhibitors	Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin	2014-02-04	$15,795,000
8604022	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof	Kevin Michael Foote, Maria-Elena Theoclitou, David Buttar	2013-12-10	$8,779,000
8129391	N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof	Kevin Michael Foote, Maria-Elena Theoclitou, David Buttar	2012-03-06	$3,533,000
RE42353	Quinazoline derivatives and pharmaceutical compositions containing them	Craig Johnstone, Edward Clayton, Elaine Sophie Elizabeth Stokes, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin	2011-05-10
7737149	N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof	David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou	2010-06-15	$9,158,000
7579344	Pyrimidine derivatives possessing cell-cycle inhibitors activity	David William Heaton	2009-08-25	$14,256,000
7579349	4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer	Thorsten Nowak	2009-08-25	$14,256,000
7521453	Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (IGF-I)	Bernard Christophe Barlaam, Andrew Pape	2009-04-21	$14,728,000
7485638	Pyrimidine compounds	Nicholas John Newcombe	2009-02-03	$10,903,000
7465728	Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity	Nicholas John Newcombe	2008-12-16	$17,796,000
7446105	Pyrimidine compounds	Nicholas John Newcombe	2008-11-04	$39,447,000
7442697	4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity	Nicholas John Newcombe	2008-10-28	$11,566,000
7427626	2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors	—	2008-09-23	$14,202,000
7173038	Quinazoline derivatives as VEGF inhibitors	Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin	2007-02-06	$11,628,000
7087602	Cinnoline derivatives and use as medicine	Laurent Francois Andre Hennequin	2006-08-08	$11,845,000
6969714	Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation	Gloria Anne Breault, Nicholas John Newcombe	2005-11-29	$11,895,000
6939872	2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors	Nicholas John Newcombe	2005-09-06	$13,785,000
6908920	Pyrimidine derivatives	Nicholas John Newcombe, David William Heaton	2005-06-21	$10,740,000
6906065	4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases	—	2005-06-14	$6,144,000
6897210	Quinazoline derivatives and pharmaceutical compositions containing them	Craig Johnstone, Edward Clayton, Elaine Sophie Elizabeth Stokes, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin	2005-05-24	$11,210,000

12 Next »

Andrew Peter Thomas — 48 Patents

Issued Patents All Time

Patent Widget